Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
Not found in filings
$25.0bn
$20.6bnEST
14-Mar-28
In March 2024, our Board of Directors granted authority to repurchase up to $25 billion in our common stock through March 14, 2028.10-Q filed 22-Sep-26
Not found in filings
$25.0bn
$21.4bnEST
30-Apr-30
In April 2026, our Board of Directors granted additional authority to repurchase up to $25 billion in our common stock through April 30, 2030.10-Q filed 22-Sep-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)